Recently, Professor An Chiying and her medical team at , China, announced a groundbreaking achievement: since June 2024, they ...

Professor Peter Johnson, NHS England’s National Clinical Director for Cancer, said: “This is one of the most hopeful advances in decades for people with bladder cancer who will now be offered a ...

Tel Aviv University announced on Wednesday that the surgery will take place in Israel, marking a historic milestone in ...

The Food and Drug Administration has granted Fast Track designation to CELZ-201-DDT for the treatment of degenerative disc disease.

NSCLC represents 80% of lung cancer cases and is the leading cause of cancer-related mortality globally. This designation is ...

Iantrek, Inc., a pioneer in bio-interventional ophthalmic surgery (BIOS), today announced the close of a $42 million Series C ...

China NMPA grants breakthrough therapy designation to Antengene’s ATG-022 to treat gastric/gastroesophageal junction adenocarcinoma: Shanghai Wednesday, August 20, 2025, 16:00 H ...

Trump administration accelerates psychedelic therapy timeline while Texas invests $50 million in breakthrough addiction ...

Infant Bacterial Therapeutics AB ( ($SE:IBT.B) ) has shared an announcement. Infant Bacterial Therapeutics AB reported no net sales for the first ...

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to ifinatamab deruxtecan (I-DXd) for the treatment of adults with extensive-stage small cell lung cancer (ES-SCLC ...